Biocon has informed that the Board of Directors of the Company at its meeting held on Thursday, May 08, 2025 has approved the audited consolidated financial statements read with the notes and schedules thereto, along with the audit report thereon for the financial year ended March 31, 2025, prepared in accordance with the requirements of the Companies Act, 2013 and Indian Accounting Standards (Ind-AS). A copy of the audited consolidated financial statements of the Company along with the audit report are enclosed. The audited consolidated financial statements read with the notes and schedules thereto, along with the audit report thereon for the financial year ended March 31, 2025, remain subject to approval of the shareholders’ at the ensuing Annual General Meeting of the Company scheduled to be held on August 08, 2025.This is in compliance under Regulation 30 and the other applicable provisions of the SEBI Listing Regulations. The above information will also be available on the website of the Company at www.biocon.com.
The above information is a part of company’s filings submitted to BSE.
